ArticleScientific reports2025
Establishment of a genotyping criteria for Bandavirus dabieense and confirmation of new genotypes.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Pre-existing immunity to heartland virus protects rhesus macaques from challenge with severe fever with thrombocytopenia syndrome virus.Emerging microbes & infections · 2026Article
- Genotype-Specific Amino Acid Signatures in the Gn/Gc Glycoprotein of Severe Fever with Thrombocytopenia Syndrome Virus Associated with Neurological Symptoms.Pathogens (Basel, Switzerland) · 2026Article
- Genetic insights into dabie bandavirus from a clinical case of severe fever with thrombocytopenia syndrome in Longyou County, China.Virology journal · 2026Article
- Multi-Epitope mRNA Vaccine TargetingBioinformatics and biology insights · 2026Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Bandavirus dabieense (DBV) causes severe fever with thrombocytopenia syndrome, which has a mortality rate of 6.18% of 27%. DBV has been classified into five to six genotypes using phylogenetic analyses. However, the absence of clear standards poses challenges in identifying new genotypes. We performed evolutionary and homology analyses using the sequences from GenBank and analysed nucleotide differences between the different genotypes. Nucleotide differences within the same genotype were mostly below 3%, whereas those between different genotypes ranged from 3 to 7%. Consequently, we established and validated a specific genotyping criterion for DBV using phylogenetic tree analysis with a 3% cut-off value and identified 8, 11, and 11 genotypes in the S, M, and L segments, respectively. Furthermore, we compared our method with the previous genotyping methods to elucidate the convenience and advantages of using a 3% cut-off value. Importantly, we also identified new genotypes and fragment reassortments in DBV using our new genotyping criterion. Additionally, we established two simplified genotyping methods for the rapid typing of DBV in clinical settings and demonstrated the existence of geographical and clinical variations among the different genotypes. Our findings provide a more reliable foundation for clinical typing of DBV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.